Steven Gill
Company: Neurochase
Job title: Founder & Chief Medical Officer
Seminars:
Improving Biodistribution Studies for Neurological Gene Therapies 1:05 pm
Understanding biodistribution in gene therapies for the CNS is holding back many therapies from regulatory approval and commercialisation so presents itself as an area in dire need for better understanding. In this workshop session, join experts in bioanalytics and biodistribution to uncover recent bioanalytical advancements in animal models to build sufficient biodistribution data to apply…Read more
day: Pre-Conference Workshop Day
An Overview of the Neurochase Delivery Technology: Targeted Delivery of CNS Therapeutics 11:00 am
An opportunity for those keen to learn more about a scalable, targeted delivery approach for CNS gene therapy deliveryRead more
day: Conference Day Two